Drugs / Cisplatin injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04379635 Background | May 2020 → Aug 2023 overdue | non-small cell lung carcinoma | BeiGene | Active not recruiting | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cisplatin injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04379635 ↗ |
| Route | Intravenous | “administered via IV infusion” NCT04379635 ↗ |